| Literature DB >> 28542573 |
Kelly Anklam1, Megan Kulow1, Wataru Yamazaki2, Dörte Döpfer1.
Abstract
Bovine digital dermatitis (DD) is a severe infectious cause of lameness in cattle worldwide, with important economic and welfare consequences. There are three treponeme phylogroups (T. pedis, T. phagedenis, and T. medium) that are implicated in playing an important causative role in DD. This study was conducted to develop real-time PCR and loop-mediated isothermal amplification (LAMP) assays for the detection and differentiation of the three treponeme phylogroups associated with DD. The real-time PCR treponeme phylogroup assays targeted the 16S-23S rDNA intergenic space (ITS) for T. pedis and T. phagedenis, and the flagellin gene (flaB2) for T. medium. The 3 treponeme phylogroup LAMP assays targeted the flagellin gene (flaB2) and the 16S rRNA was targeted for the Treponeme ssp. LAMP assay. The real-time PCR and LAMP assays correctly detected the target sequence of all control strains examined, and no cross-reactions were observed, representing 100% specificity. The limit of detection for each of the three treponeme phylogroup real-time PCR and LAMP assays was ≤ 70 fg/μl. The detection limit for the Treponema spp. LAMP assay ranged from 7-690 fg/μl depending on phylogroup. Treponemes were isolated from 40 DD lesion biopsies using an immunomagnetic separation culture method. The treponeme isolation samples were then subjected to the real-time PCR and LAMP assays for analysis. The treponeme phylogroup real-time PCR and LAMP assay results had 100% agreement, matching on all isolation samples. These results indicate that the developed assays are a sensitive and specific test for the detection and differentiation of the three main treponeme phylogroups implicated in DD.Entities:
Mesh:
Year: 2017 PMID: 28542573 PMCID: PMC5444799 DOI: 10.1371/journal.pone.0178349
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers and fluorescence-labeled oligonuclueotide probes for the three real-time PCR assays.
| Target Gene | Primer/Probe Specificity | Primer/Probe Sequence (5'-3') | Amplicon (bp) | Position | Accession Number |
|---|---|---|---|---|---|
| 16S-tRNAIle region | 109–128 | AF179255 | |||
| 118 | 226–208 | ||||
| 207–182 | |||||
| 16S-tRNAIle region | 87–110 | AF179261 | |||
| 104 | 190–172 | ||||
| 171–146 | |||||
| 369–386 | EF061271 | ||||
| 122 | 490–471 | ||||
| 411–440 |
Primers for the four LAMP assays.
| Target Gene | Primer Specificity | LAMP Primer | Primer Sequence (5'-3') |
|---|---|---|---|
| 16S rRNA | F3 | ||
| B3 | |||
| FIP | |||
| BIP | |||
| LF | |||
| LB | |||
| F3 | |||
| B3 | |||
| FIP | |||
| BIP | |||
| LF | |||
| LB | |||
| F3 | |||
| B3 | |||
| FIP | |||
| BIP | |||
| LF | |||
| F3 | |||
| B3 | |||
| FIP | |||
| BIP | |||
| LF | |||
| LB |
The Treponema species primer was designed to encompass T. pedis, T. phagedenis, and T. medium.
bThere is no LB primer for the T. phagedenis due to unfavorable sequence in that location. The loop primers (LB and LF) are not necessary for the LAMP assay to perform however the loop primers increase efficiency.
Bacterial strains used for the development of the real-time PCR and LAMP assays.
| Bacterial strain | No. of strains tested |
|---|---|
| 6 | |
| 18 | |
| 10 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 |
aUniversity of Wisconsin-Madison—Döpfer, Madison, WI
bUniversity of California-Davis, Davis, CA.
cAmerican Type Culture Collection, Manassas, VA
dVeterinary Medicine Teaching Hospital, Madison, WI
eFood Research Insitiute–Kasper, Madison, WI
Detection limits and results of the regression analysis of the real-time PCR assays.
| Real-time PCR Target | Detection Limit (fg/μl) | R2 | Efficiency |
|---|---|---|---|
| 69 | 0.995 | 1.99 | |
| 70 | 0.997 | 2.03 | |
| 59 | 0.998 | 1.92 |
aE = 10(-1/Slope), 2.00 = 100% Efficiency
DD lesion biopsy survey results.
| Sample ID | DD Lesion | Chronicity | Steer Type | ||||
|---|---|---|---|---|---|---|---|
| 1 | M2 | None | 2 | + | - | - | - |
| 2 | M2 | None | 2 | + | - | + | - |
| 3 | M2 | Proliferative | 2 | + | + | - | + |
| 4 | M2 | Hyperkeratotic | 2 | + | + | + | - |
| 5 | M2 | Proliferative | 2 | + | + | + | - |
| 6 | M2 | Proliferative | 2 | + | - | + | + |
| 7 | M2 | Proliferative | 2 | + | - | + | + |
| 8 | M2 | Proliferative | 2 | + | - | + | - |
| 9 | M2 | Proliferative | 2 | + | - | + | - |
| 10 | M4.1 | Proliferative | 2 | + | - | + | + |
| 11 | M2 | Hyperkeratotic | 2 | + | + | - | + |
| 12 | M2 | Proliferative | 2 | + | + | - | + |
| 13 | M2 | Hyperkeratotic | 2 | + | + | + | - |
| 14 | M4.1 | Proliferative | 2 | + | + | + | - |
| 15 | M2 | Proliferative | 2 | + | + | + | - |
| 16 | M4.1 | Proliferative | 2 | + | - | + | - |
| 17 | M4.1 | Proliferative | 2 | + | - | + | - |
| 18 | M4 | Hyperkeratotic | 2 | + | - | + | - |
| 19 | M4 | Hyperkeratotic | 2 | + | - | + | - |
| 20 | M2 | None | 2 | + | - | + | - |
| 21 | M2 | Proliferative | 2 | + | - | + | - |
| 22 | M4.1 | Proliferative | 2 | + | - | + | - |
| 23 | M2 | Proliferative | 2 | + | - | + | - |
| 24 | M2 | Proliferative | 2 | + | - | + | - |
| 25 | M2 | Proliferative | 2 | + | - | + | - |
| 26 | M4 | Hyperkeratotic | 2 | + | + | + | + |
| 27 | M2 | Proliferative | 2 | + | + | + | + |
| 28 | M2 | Proliferative | 2 | + | - | - | - |
| 29 | M4 | Hyperkeratotic | 3 | + | - | + | + |
| 30 | M2 | Proliferative | 3 | + | + | + | + |
| 31 | M2 | Proliferative | 3 | + | + | - | + |
| 32 | M2 | Proliferative | 3 | + | + | + | - |
| 33 | M4 | Proliferative | 3 | + | + | - | - |
| 34 | M4.1 | Hyperkeratotic | 3 | + | - | + | + |
| 35 | M2 | Hyperkeratotic | 3 | + | - | + | - |
| 36 | M2 | None | 3 | + | - | + | - |
| 37 | M2 | Proliferative | 3 | + | - | + | - |
| 38 | M2 | Proliferative | 3 | + | - | + | - |
| 39 | M2 | Proliferative | 3 | + | - | + | - |
| 40 | M2 | Proliferative | 3 | + | - | + | - |